The successful transplantation of vascularized limbs or even other vascularized blocks of tissue (composite tissue allograft modules; CTA) would have profound implications in reconstructive surgery. CTAs or substructures thereof would be useful for constructing severe musculoskeletal defects. The final goal of these studies is to lay the experimental foundation for the ultimate clinical exploitation of CyA and CTAs. The rat hind limb serves as an excellent vascularized model of a CTA composed of skin, subsutaneous fat, muscle, synovial joints, bone, bone-marrow, and neurovascular structures. The rat limb offers a unique model to study each individual tissue within a well defined histocompatibility system. We have established the first principle necessary for the contemplation of utilizing CTAs combined with cyclosporine clinically: namely, that a minimal CyA dose is effective for preventing rejection (1). Secondly, we have also established that composite tissue allografts transplanted across this major histocompatibility barrier can demonstrated indefinite survival with moderate doses of cyclosporine with no inherent toxicity (2). Thus, we believe that the clinical potential for CTAs is even more promising today than we had originally envisioned. We intend to further study methods aimed at achieving indefinite or long-term allograft survival in combination with the use of CyA. The immune status of long-term surviving, chimeric, and apparently tolerant CTA recipients (2,3) will be characterized. Unique rejection processes will be further delineated histothologically. A new dose-response curve will be established across a much stronger histocompability barrier (ACI-greater than LEW; Rt-1 a-greater than 1) to convincingly confirm cyclosporine's potential for preventing CTA rejection at relatively low doses. We propose to characterizing the possible development of lymphoid chimerism and thus potential graft versus host disease in this strong fully allogeneic CTA model with sensitive fluorescence activated cell sorter analysis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
2R01AR032263-04
Application #
3156243
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1983-12-01
Project End
1989-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Type
Schools of Medicine
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Patam, M A; Tran, H S; Llull, R et al. (2000) Site-specific immunosuppression: mechanisms of cellular immunosuppression that are operative at local and systemic levels. J Burn Care Rehabil 21:9-Oct
Ramsamooj, R; Llull, R; Black, K S et al. (1999) Composite tissue allografts in rats: IV. Graft-versus-host disease in recipients of vascularized bone marrow transplants. Plast Reconstr Surg 104:1365-71
Balkian, G K; Flores, K M; Llull, R et al. (1997) A rapid and sensitive cellular enzyme-linked immunoabsorbent assay (CELISA) for the detection and quantitation of antibodies against cell surface determinants. II. Optimal reagent concentrations and predictive analysis. Cell Transplant 6:431-7
Ramsamooj, R; Patel, M P; Llull, R et al. (1996) Use of regression analysis and flow cytometry for determining levels of mixed semiallogeneic immune chimerism. J Invest Surg 9:273-81
Llull, R; Ramsamooj, R; Black, K S et al. (1994) Cellular mechanisms of alloimmune non-responsiveness in tolerant mixed lymphocyte chimeras induced by vascularized bone marrow transplants. Transpl Int 7 Suppl 1:S453-6
Walker, K W; Llull, R; Balkian, G K et al. (1992) A rapid and sensitive cellular enzyme-linked immunoabsorbent assay (CELISA) for the detection and quantitation of antibodies against cell surface determinants. I. A comparison of cell fixation and storage techniques. J Immunol Methods 154:121-30
Yazdi, B; Patel, M P; Ramsamooj, R et al. (1991) Vascularized bone marrow transplantation (VBMT): induction of stable mixed T-cell chimerism and transplantation tolerance in unmodified recipients. Transplant Proc 23:739-40
Hewitt, C W; Ramsamooj, R; Patel, M P et al. (1990) Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts. Transplantation 50:766-72
Hewitt, C W; Black, K S; Gratwohl, A et al. (1990) Lethal cyclosporine associated toxicity in the rabbit: similar findings in two distant and independent transplant laboratories. J Clin Lab Immunol 31:23-5
Hewitt, C W; Black, K S; Achauer, B M et al. (1990) Reconstructive allotransplantation: considerations regarding integumentary/musculoskeletal grafts, cyclosporine, wound coverage in thermal injury, and the immune response. J Burn Care Rehabil 11:74-85

Showing the most recent 10 out of 19 publications